Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis

Autoimmunity

Volumn 42, Issue 4, 2009, Pages 305-307

  Urbonaviciute, Vilma ^a   Meister, Silke ^a   Frnrohr, Barbara G ^a   Frey, Benjamin ^a   Gckel, Eva ^a   Schett, Georg ^a   Herrmann, Martin ^a   Voll, Reinhard E ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Apoptosis; HMGB1; Necrosis; Oxidation

Indexed keywords

CYSTEINE; HIGH MOBILITY GROUP B1 PROTEIN; MACROGOL; MALEIMIDE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OXIDATION; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; REDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

APOPTOSIS; CYSTEINE; HMGB1 PROTEIN; HUMANS; JURKAT CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NECROSIS; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 70749150007     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930902831803     Document Type: Article

References (11)

1. Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 2007;220:35-46.
2. Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med 2008;205(13): 3007-3018.
3. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M. Impaired uptake of apo cells into tingible body macrophages in germinal centers of patients with SLE. Arthritis Rheum 2002;46(1):191-201.
4. Urbonaviciute V, Furnrohr BG, Weber C, Haslbeck M, Wilhelm S, Herrmann M, Voll RE. Factors masking HMGB1 in human serum and plasma. J Leukoc Biol 2007;81(1): 67-74.
5. Hoppe G, Talcott KE, Bhattacharya SK, Crabb JW, Sears JE. Molecular basis for the redox control of nuclear transport of the structural chromatin protein HMGB1. Exp Cell Res 2006;312(18):3526-3538.
6. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tor M, Billiar T. The grateful dead: Damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007;220:60-81.
7. Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apo. J Immunol Methods 2002;265(1-2):49-72.
8. Wu HH, Thomas JA, Momand J. p53 Protein oxidation in cultured cells in response to pyrrolidine dithiocarbamate: A novel method for relating the amount of p53 oxidation in vivo to the regulation of p53-responsive genes. Biochem J 2000;351(Pt 1):87-93.
9. Hill DA, Pedulla ML, Reeves R. Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1. Nucleic Acids Res 1999;27(10):2135-2144.
10. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, Witztum JL. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005;25(6):1213-1219.
11. Kurien BT, Hensley K, Bachmann M, Scofield RH. Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 2006;41(4):549-556.